Differential behaviors of trastuzumab-sensitive and -resistant SKBR3 cells treated with menadione reveal the involvement of Notch1/Akt/FOXO1 signaling elements
- 27 June 2015
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 408 (1-2) , 89-102
Abstract
Given that HER2 serves as a putative target for therapy in HER2-positive breast cancer, intrinsic and/or acquired resistance to trastuzumab (T) has been proposed to be the major obstacle in treatments. In addition, chemoresistance is commonly attributed to increased antioxidant capacity. In that regard, we evaluated the effect of menadione (M) alone and/or its combination with trastuzumab on proliferation, intracellular GSH and ROS contents as well as HER2 and Notch1 signaling pathways in both trastuzumab-resistant (SKBR3R) and -sensitive SKBR3 (SKBR3S) cells. In spite of increased level of ROS and reduced level of GSH in M-treated SKBR3S cells, M-treated SKBR3R cells showed a decreased content of ROS and GSH compared to untreated cells. However, M/T co-treatment of SKBR3 cells indicated no effect on ROS content, while decreased the level of GSH compared to untreated control cells. Based on the extent of apoptosis, colony formation and wound healing assays, M alone, and/or in combination with T had a stronger inhibitory effect on proliferation of SKBR3R cells relative to SKBR3S cells. These effects might be due to the stronger effects of M and/or M/T on downregulation of p-Akt, Hes1, NICD, and upregulation of FOXO1 among SKBR3R cells relative to the sensitive SKBR3 cells. These findings would certainly shed light on some of the signaling factors involved in induction of trastuzumab resistance and would be of value in designing more efficient chemosensitization strategies.Keywords
This publication has 46 references indexed in Scilit:
- ErbB1/2 tyrosine kinase inhibitor mediates oxidative stress-induced apoptosis in inflammatory breast cancer cellsBreast Cancer Research and Treatment, 2011
- Pancreatic Tumor Suppression by Benzyl Isothiocyanate Is Associated with Inhibition of PI3K/AKT/FOXO PathwayClinical Cancer Research, 2011
- Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesisMolecular Cancer, 2009
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent PathwaysJournal of Biological Chemistry, 2009
- Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cellsGene, 2004
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- Cellular response to oxidative stress: Signaling for suicide and survival*Journal of Cellular Physiology, 2002
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Mitomycin C and menadione for the treatment of lung cancer: a phase II trialInvestigational New Drugs, 1995
- Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stressChemical Research in Toxicology, 1992